Answers are grounded in this paper and cite their sources.
Monoclonal antibodies are widely used to treat cancer and autoimmune diseases, and Chinese hamster ovary (CHO) cells are the primary host for their production. Antibodies comprise multiple polypeptide chains and precise and coordinated gene expression is essential to optimize productivity and product quality. Here, we developed a regulated expression system based on artificial transcription factors (aTFs) and applied it to full-length IgG production. Heavy- and light-chain genes were placed under unidirectional or bidirectional TRE promoters, enabling inducible, coordinated expression through aTF coregulation. The optimal vector configuration was identified, and a stable CHO clone (CHO/B-HL) was established and adapted to serum-free suspension culture. In batch culture, temperature downshift from 37°C significantly enhanced antibody production. Deep hypothermic cultivation at 30°C increased specific productivity (>8-fold) compared with standard conditions, reaching 81.3 pg cell -1 d -1 . In semi-continuous high-density culture, antibody titers were maintained above 4 g/L for over 30 days in the absence of antibiotic selection, with sustained specific productivity up to 71.4 pg cell -1 d -1 . SDS-PAGE analysis confirmed correct H 2 L 2 assembly of the secreted antibodies. In summary, aTF-driven regulated expression provides a robust, process-compatible strategy for sustained, high-level monoclonal antibody production in CHO cells, offering a viable alternative to conventional constitutive expression systems.
No takes yet. Share an insight, caveat, or question.
Tanno et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: